Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Jan
9
2024
5th Circuit Issues Blistering Critique of FDA’s Handling of PMTAs for E-Cigarettes Keller and Heckman LLP
Jan
9
2024
CORE Releases 2022 Annual Outbreak Report Keller and Heckman LLP
Jan
9
2024
Malta Initiative Survey on OECD Test Guidelines and Guidance Documents Will Close January 12 Bergeson & Campbell, P.C.
Jan
9
2024
Blazing Trails: Exploring ESOPs in the Cannabis Industry Bradley Arant Boult Cummings LLP
Jan
8
2024
Gold Dome Report – Legislative Day 1 (2024) Nelson Mullins
Jan
8
2024
HHS, ONC HTI-1 Final Rule Introduces New Transparency Requirements for Artificial Intelligence in Certified Health IT Mintz
Jan
8
2024
Extended Producer Responsibility for Packaging: What’s Ahead in 2024 Hunton Andrews Kurth
Jan
5
2024
Trending in Telehealth: December 21, 2023 – January 3, 2024 McDermott Will & Emery
Jan
5
2024
Texas Urges Federal Court to Toss Tofurky Challenge of Labeling Law Keller and Heckman LLP
Jan
5
2024
McDermottPlus Check-Up: January 5, 2024 McDermott Will & Emery
Jan
5
2024
Hospital and MA Plan Considerations for CMS Final Rule to Remedy 340B Drug Payment Policy Epstein Becker & Green, P.C.
Jan
4
2024
With Increased New York Minimum Wage Come Modified Obligations Under State Wage Orders Jackson Lewis P.C.
Jan
4
2024
2023: A Good Trip Around the Sun for Psychedelics Bradley Arant Boult Cummings LLP
Jan
4
2024
Not So Fast My Friend: Alabama Medical Commission Halts Issuance of Integrated (and Probably Dispensary) Licenses Bradley Arant Boult Cummings LLP
Jan
4
2024
Brand Selection Primer for Emerging Healthy F&B Companies Foley & Lardner LLP
Jan
4
2024
FDA Announces Availability of Cosmetics Direct Portal and Publication of Final Guidance on Cosmetic Facility Registration and Product Listing ArentFox Schiff LLP
Jan
4
2024
Acetaminophen MDL: Judge Excludes All of Plaintiffs’ Causation Experts Pursuant to Newly-Amended FRE Rule 702 Foley & Lardner LLP
Jan
4
2024
Espresso Yourself: When Prosecution History as a Whole Doesn’t Demonstrate Clear, Unmistakable Disclaimer McDermott Will & Emery
Jan
4
2024
Same Applicant, Similar Claims Support Obviousness-Type Double Patenting Rejection McDermott Will & Emery
Jan
3
2024
NIOSH Reviews Past Nanotechnology Guidance and Needs for Future Research Bergeson & Campbell, P.C.
Jan
3
2024
DOT Random Drug and Alcohol Testing Rates for 2024 Jackson Lewis P.C.
Jan
3
2024
Defending Psychedelics: Congress Includes Psychedelic Provisions in Defense Authorization Act Bradley Arant Boult Cummings LLP
Jan
3
2024
Federal Circuit Clarifies Reach of “Artificial” Act of Patent Infringement Proskauer Rose LLP
Jan
3
2024
Unpacking Averages: The Seasonality of FDA 510(k) Decision-Making and the Impact of Michigan Playing for a National Championship Epstein Becker & Green, P.C.
Jan
3
2024
FDA Supplements Response to D-Tagatose Petition Keller and Heckman LLP
Jan
3
2024
FDA Issues Guidance on Reformulating Drug Products that Contain Carbomers Manufactured with Benzene Keller and Heckman LLP
Jan
3
2024
APHIS Reopens Comment Period on Proposed Additional Exemptions for Plants Modified or Produced Through Genetic Engineering Bergeson & Campbell, P.C.
Jan
2
2024
New U.S. Action Against Wine Bottle Imports Squire Patton Boggs (US) LLP
Jan
2
2024
US State Law Roundup – 2023 Year-end Update Squire Patton Boggs (US) LLP
Jan
2
2024
The Intertwining Nature of Motivation to Combine and Reasonable Expectation of Success Sheppard, Mullin, Richter & Hampton LLP
Jan
2
2024
Looking Back and Moving Forward: MoCRA Regulatory Developments Ring in the New Year Mintz
Jan
2
2024
Prop 12 Takes Full Effect in California Keller and Heckman LLP
Dec
29
2023
OSTP Publishes Report on Vision, Needs, and Proposed Actions for Data for the Bioeconomy Initiative Bergeson & Campbell, P.C.
Dec
29
2023
EPA Registers Novel Pesticide Technology for Potato Crops Bergeson & Campbell, P.C.
Dec
28
2023
Two-Dimensional Barcodes: How 2D Could Change Retail Foley & Lardner LLP
Dec
27
2023
NNI Publishes Economic Impact Analysis of 20 Years of Nanotechnology Investments Bergeson & Campbell, P.C.
Dec
27
2023
Postal ServiceTM Proposes New Mailing Standards for Hazardous Materials Outer Packaging and Nonregulated Toxic Materials Bergeson & Campbell, P.C.
Dec
26
2023
CMS Issues Revised Guidance Implementing Medicare Inflation Rebates Under the Inflation Reduction Act ArentFox Schiff LLP
Dec
23
2023
China’s National Intellectual Property Administration to Allow Third-Party Challenges to Pharmaceutical Patent Term Extensions Schwegman, Lundberg & Woessner, P.A.
Dec
22
2023
Private Investors and Digital Health Attracting OIG Attention: General Compliance Program Guidance to Watch McDermott Will & Emery
Dec
22
2023
Medicare Provider and Supplier Enrollment Requirements: Program Integrity Changes for 2024 McDermott Will & Emery
Dec
21
2023
China’s State Council Releases Amended Implementing Regulations of the Patent Law Schwegman, Lundberg & Woessner, P.A.
Dec
21
2023
Pharmaceutical Companies Have Rights if the Federal Government Seized their Patents Sheppard, Mullin, Richter & Hampton LLP
Dec
21
2023
Inherent Limitations in Prior Patents can Lead to Obviousness-Type Double-Patenting Mintz
Dec
21
2023
FDA Announces Updated Instructions for Serious Adverse Event Reporting for Cosmetic Products ArentFox Schiff LLP
Dec
21
2023
FSA Assesses Oyster Import Risks Keller and Heckman LLP
Dec
21
2023
APHIS Extends Comment Period on Proposed Exemptions for Genetically Modified Plants Keller and Heckman LLP
Dec
21
2023
Australia and New Zealand Consult on the First Cell-Cultured Meat Application Keller and Heckman LLP
Dec
20
2023
2023: Another Year Chock Full of Challenges for FDA Mintz
Dec
20
2023
Boosting Biotech: New York City Revives Tax Credits for Emerging Companies Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins